Preparation of (S)-tert-ButylPyOx and Palladium-Catalyzed Asymmetric Conjugate Addition of Arylboronic Acids by Holder, Jeffrey C. et al.
  
 
Org. Synth. 2015, 92, 247-266                                   Published on the Web 8/7/2015 
DOI: 10.15227/orgsyn.092.0247                                                              © 2015 Organic Syntheses, Inc. 
 
247 
 
Preparation	  of	  (S)-­‐tert-­‐ButylPyOx	  and	  Palladium-­‐
Catalyzed	  Asymmetric	  Conjugate	  Addition	  of	  Arylboronic	  
Acids	  	  
	  
Jeffrey C. Holder, Samantha E. Shockley, Mario P. Wiesenfeldt, 
Hideki Shimizu, and Brian M. Stoltz*1 
 
The Warren and Katharine Schlinger Laboratory for Chemistry and 
Chemical Engineering, Division of Chemistry and Chemical Engineering, 
California Institute of Technology, 1200 East California Boulevard, MC 101-
20, Pasadena, California, 91125, United States  
 
Checked by Brian M. Cochran and Margaret Faul 
 
 
 
  
 
	  
	  
	  
O
Me
O
Me
Cl
+
Cl
B(OH)2
Pd(OCOCF3)2, (S)-tert-BuPyOx (3),
NH4PF6, H2O
ClCH2CH2Cl, 40 °C
C.
B.
N
O
H
N OH
t-Bu
1. SOCl2, toluene, 60 °C
2. NaOMe, MeOH, 55 °C
N
N
O
t-Bu
A.
N
1. i-BuOCOCl, NMM, CH2Cl2, 0 °C
2. (S)-tert-leucinol, NMM, CH2Cl2
0 °C → 23 °CCO2H
N
O
H
N OH
t-Bu
1 2
2 3
4 5 6
 Org. Synth. 2015, 92, 247-266                        DOI: 10.15227/orgsyn.092.0247 
 
248 
Procedure	  
 
A.  (S)-N-(1-Hydroxy-3,3-dimethylbutan-2-yl)picolinamide (2). A 1 L one-
necked round-bottomed flask equipped with a 3.0 cm x 1.4 cm, egg-shaped, 
Teflon-coated magnetic stirring bar is sealed with a septum and connected 
via needle adapter to a two-tap Schlenk adapter attached to an oil bubbler 
and a nitrogen/vacuum manifold (Note 1).  The flask is dried with a heat 
gun under vacuum and cooled under a stream of nitrogen.  The flask is 
charged with 2-picolinic acid (1) (6.15 g, 50.0 mmol, 1.00 equiv) (Note 2), 
evacuated and back-filled with nitrogen three times, then charged with 
dichloromethane (300 mL, 0.17 M) (Note 3) and N-methylmorpholine 
(7.59 g, 8.25 mL, 75.0 mmol, 1.50 equiv).  The flask is cooled in an ice/water 
bath and iso-butylchloroformate (6.86 mL, 7.17 g, 52.5 mmol, 1.05 equiv) is 
added dropwise over 30 min by syringe pump.  The reaction mixture is 
stirred for an additional 30 min while remaining submerged in the 
ice/water bath.  A separate 100 mL one-necked round-bottomed flask is 
sealed with a septum and connected via needle adapter to the two-tap 
Schlenk adapter and manifold, dried with a heat gun under vacuum, and 
allowed to cool under a stream of nitrogen.  This flask is charged with (S)-
tert-leucinol (6.45 g, 55.0 mmol, 1.10 equiv), dichloromethane (40 mL), and 
N-methylmorpholine (6.07 mL, 5.56 g, 55.0 mmol, 1.10 equiv).  The resulting 
clear solution is taken up in a syringe and transferred dropwise using a 
syringe pump over the course of 1 h to the stirring reaction mixture in the 
ice/water bath.  The cooling bath is removed, and the pale gold colored 
reaction mixture is stirred for an additional 6 h at 23 °C.  Upon consumption 
of starting material (Note 4), the mixture is quenched at ambient 
temperature with a single addition of an aqueous solution of saturated 
NH4Cl (50 mL), diluted with additional H2O (25 mL), and transferred into a 
1 L separatory funnel.  The phases are separated, and the aqueous phase is 
extracted with CH2Cl2 (3 x 100 mL).  The combined organic phases are 
washed with an aqueous solution of saturated NaHCO3 (1 x 50 mL) and 
brine (1 x 50 mL).  The combined organic phases are dried over Na2SO4 (10 
g, 15 min while agitating), filtered through a M pore glass frit, and 
concentrated by rotary evaporation (28 °C, 15 mmHg). Excess N-
methylmorpholine is further removed by placing the crude residue under 
high vacuum (< 12 mmHg, 12 h) to provide a pale red solid (Note 5).  The 
crude residue is dissolved in 10 mL of acetone and purified via silica gel 
flash chromatography (Note 6).  The combined product-containing fractions 
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are concentrated by rotary evaporation (40 °C, 15 mmHg) to yield a solid, 
which is dried under high vacuum (< 12 mmHg, 12 h) to afford (S)-N-(1-
hydroxy-3,3-dimethylbutan-2-yl)picolinamide (2) as a white amorphous 
solid (9.88–9.95 g, 44.4–44.8 mmol, 89–90% yield) (Note 7). 
B.  (S)-4-(tert-Butyl)-2-(pyridin-2-yl)-4,5-dihydrooxazole (3). A 500 mL 
three-necked round-bottomed flask is equipped with a 3.0 cm x 1.4 cm, egg-
shaped, Teflon-coated magnetic stirring bar.  All necks are sealed with 
rubber septa and the center neck is attached via needle adapter to a two-tap 
Schlenk adapter connected to a bubbler and a nitrogen/vacuum manifold 
(Note 1).  One side neck is fitted with a thermometer pierced through a 
rubber septum.  The flask is dried with a heat gun under vacuum, cooled 
under a stream of nitrogen and charged with (S)-N-(1-hydroxy-3,3-
dimethylbutan-2-yl)picolinamide (2) (8.89 g, 40.0 mmol, 1.00 equiv) and 
toluene (140 mL, 0.285 M) (Note 3).  The resulting clear solution is heated at 
60 °C in a preheated bath of armor beads (Note 8).  In a separate 50 mL 
flask, SOCl2 (5.64 mL, 80.0 mmol, 2.00 equiv, Note 2) is dissolved in toluene 
(20 mL) and taken up with a syringe.  The SOCl2 solution is added dropwise 
over 70 min to the vigorously stirring reaction mixture using a syringe  
 
 
 
pump (Note 9). Upon complete addition, the mixture is stirred for an 
additional 4 h.  The resulting slurry is allowed to cool to ambient 
temperature, concentrated by rotary evaporation (55 °C, 15 mmHg), 
crushed with a spatula, and further dried under high vacuum (< 12 mmHg, 
12 h) to afford (S)-N-(1-chloro-3,3-dimethylbutan-2-yl)picolinamide 
hydrochloride salt as a tan powder (10.68–10.86 g, 38.5–39.2 mmol, 96–98% 
yield) (Note 10).  This material is used without purification.   
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A 500 mL one-necked round-bottomed flask equipped with a 3.0 cm x 
1.4 cm, egg-shaped, Teflon-coated magnetic stirring bar is charged with (S)-
N-(1-chloro-3,3-dimethylbutan-2-yl)picolinamide hydrochloride salt 
(10.26 g, 37.0 mmol, 1.00 equiv) and methanol (100 mL, 0.37 M) (Note 3).  To 
the clear, stirring solution is added powdered sodium methoxide (9.99 g, 
185.0 mmol, 5.00 equiv) (Notes 2 and 11) in one portion, and the resulting 
mixture is lowered into an armor bead bath preheated at 55 °C.  The slurry 
 
   
 
is stirred for 18 h (Note 12). Afterwards, the armor bead bath is removed, 
the reaction is allowed to cool to ambient temperature, and toluene 
(100 mL) is added (Note 13).  The reaction mixture is partially concentrated 
by rotary evaporation to remove the methanol (40 °C, 60 mmHg), at which 
time the resulting slurry is transferred to a 250 mL separatory funnel and 
washed with water (100 mL) (Note 14).  The layers are separated, and the 
aqueous layer is back extracted with toluene (3 x 40 mL).  The combined 
organic extracts are dried over Na2SO4 (20 g) with stirring for 20 min, 
filtered through a M pore glass frit, and concentrated by rotary evaporation 
(40 °C, 15 mmHg).  The crude residue is purified by silica gel flash 
chromatography (Note 15). The combined product-containing fractions are 
concentrated by rotary evaporation (28 °C, 15 mmHg) to yield a solid, 
which is further dried under high vacuum (< 12 mmHg, 12 h) to afford (S)-
tert-ButylPyOx (3) as a white solid (5.64–5.91 g, 27.6–28.9 mmol, 75–78% 
yield; 72–76% yield from 2) (Note 16). 
C.  (R)-3-(4-Chlorophenyl)-3-methylcyclohexanone (6).  A 500 mL, one-
necked round-bottomed flask is equipped with a 4.2 x 2.0 cm, egg-shaped, 
Teflon-coated magnetic stirring bar and charged sequentially with 1,2-
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dichloroethane (150 mL, 0.23 M), (S)-tert-ButylPyOx (3) (0.429 g, 2.10 mmol, 
0.06 equiv), palladium(II) trifluoroacetate (0.582 g, 1.75 mmol, 0.05 equiv), 
ammonium hexafluorophosphate (1.71 g, 10.5 mmol, 0.30 equiv), and 
4-chlorophenylboronic acid (5) (6.57 g, 42 mmol, 1.2 equiv) (Note 2).  The 
suspension is stirred at ambient temperature for 5 min, at which time a pale 
yellow color is observed.  Not all solids are dissolved at this time. 3-Methyl-
2-cyclohexenone (4) (3.97 mL, 35.0 mmol, 1 equiv) is transferred via syringe 
to the stirring suspension at ambient temperature. Water (3.15 mL, 
175 mmol, 5 equiv) (Note 3) is added in one portion via syringe to the 
stirring mixture and the flask is placed in an armor bead bath preheated at 
40 °C.  The reaction is vigorously stirred for 12–24 h (Note 17). 
 
   
	  
Upon consumption of the starting material (Note 18), the reaction is cooled 
to ambient temperature and stirring is halted, allowing the solids to settle.  
The reaction mixture, including the solid matter, is filtered over a pad of 
silica gel (Note 19).  The filter cake is washed with additional 1,2-
dichloroethane (150 mL).  The filtrate is concentrated by rotary evaporation 
(28 °C, 15 mmHg) and the crude residue is purified by silica gel flash 
chromatography (Note 20).  The combined product-containing fractions are 
concentrated by rotary evaporation (28 °C, 15 mmHg) to yield a solid, 
which is further dried under high vacuum (< 12 mmHg, 12 h) to afford (R)-
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3-(4-chlorophenyl)-3-methylcyclohexanone (6) (6.80–7.07 g, 30.5–31.7 mmol, 
87–91% yield, 93% ee) as a colorless crystalline solid (Note 21).    
	  
	  
Notes	  
 
1. A two-tap Schlenk adapter connected to a bubbler and an 
argon/vacuum manifold is illustrated in Yu, J.; Truc, V.; Riebel, P.; 
Hierl, E.; Mudryk, B. Org. Synth. 2008, 85, 64–71. 
2. Iso-butylchloroformate (98%) and 2-picolinic acid (99%) were purchased 
from Acros Organics and used without further purification. N-
Methylmorpholine (redistilled, >99.5%), thionyl chloride (>99%), 
sodium methoxide (95%), ammonium hexafluorophosphate (99.9%), 
and (S)-tert-leucinol (98%) were purchased from Sigma Aldrich and 
used as received.  The submitters prepared (S)-tert-leucinol as described 
by Krout, M. R.; Mohr, J. T.; Stoltz, B. M.  Org. Synth. 2009, 86, 181–193.    
4-Chlorophenylboronic acid (98%) and 3-methylcyclohexen-1-one (98%) 
were purchased from Combi-Blocks and used as received. The 
submitters noted a variation in ee and yield with different commercial 
sources and batches of 4-chlorophenylboronic acid, presumably due to 
the presence of variable amounts of boroxine. Palladium(II) 
trifluoroacetate (97%) was purchased from Strem Chemicals and  3-
methylcyclohexen-1-one (98%) was purchased from Combi-Blocks, and 
each was used as received.  
3. Methylene chloride (> 99.8%, anhydrous), toluene (99.8%, anhydrous), 
methanol (99.8%, anhydrous) and reagent grade 1,2-dichloroethane 
(99.8%, anhydrous) were purchased from Sigma Aldrich and used as 
received. In house deionized water was used without alteration.  
4. The reaction can be monitored by TLC analysis using 3:2 
hexanes/acetone as the eluent (E. Merck Silica gel 60 F254 precoated 
plates, 250 nm), visualizing with UV fluorescence quenching and 
p-anisaldehyde staining or iodine staining.  Product amide (2) Rf = 0.42, 
impurity Rf = 0.38 (consistent with 3,3-dimethyl-2-(picolinamido)butyl 
picolinate), N-methylmorpholine Rf = 0.06 (iodine stain). Picolinic acid 
(1) and tert-leucinol remain at the baseline (Rf = 0), as determined by 
TLC.     
5. If N-methylmorpholine is not removed prior to chromatography, it will 
overload the silica gel column and will contaminate product fractions. 
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Excess N-methylmorpholine complicates product solidification post 
chromatography.   
6. Silica gel column dimensions: 5 cm diameter x 20 cm height, ca. 220 g 
silica gel (RediSep RF column from Teledyne Isco, catalog 69-2203-422), 
eluting with 4:1 hexanes/acetone. Pre-run of 200 mL is collected before 
fractions are taken.  Fractions are collected in 18 mm x 150 mm test 
tubes.  Fraction purity can be assayed by TLC analysis using 3:2 
hexanes/acetone with UV visualization. Product (2) Rf = 0.42, impurity 
Rf = 0.38 (consistent with 3,3-dimethyl-2-(picolinamido)butyl 
picolinate), N-methylmorpholine Rf = 0.06 (iodine stain). Both starting 
materials remain at the baseline (Rf = 0).  
7. (S)-N-(1-Hydroxy-3,3-dimethylbutan-2-yl)picolinamide (2) exhibited the 
following characterization data: Rf = 0.42 with 3:2 hexanes/acetone; 
mp 78.7–79.8 °C; 1H NMR (400 MHz, CDCl3) δ: 1.05 (s, 9 H), 2.60 (br s, 
1 H), 3.70 (dd, J = 8.4, 11.2 Hz, 1 H), 3.96–4.03 (m, 2 H), 7.44 (dd, J = 5.2, 
6.8 Hz, 1 H), 7.85 (dt, J = 1.2, 8.0 Hz, 1 H), 8.19 (d, J = 8.0 Hz, 1 H), 8.32 
(br d, J = 8.0 Hz, 1 H), 8.56 (d, J = 4.8 Hz, 1 H); 13C NMR (100 MHz, 
CDCl3) δ: 27.0, 33.7, 60.5, 63.6, 122.4, 126.2, 137.4, 148.0, 149.6, 165.5; 
IR (film): 3390, 3241, 2966, 1646, 1535, 1464, 1435, 1368, 1293, 1241, 1083, 
1054, 1022, 999, 863, 750, 697 cm-1; HRMS (Multimode ESI/FTMS) m/z 
calcd for C12H19N2O2 [M + H]+: 223.1441, found: 223.1439;  [α]D24 = –9.09 
(c 1.728, CHCl3); Anal calcd for C12H18N2O2:  C, 64.84; H, 8.17; N, 12.61. 
Found: C, 64.65; H, 8.19; N, 12.60.  
8. The submitters used an oil bath heated to 60 °C. 
9. Care should be taken to ensure the addition rate is initially very slow to 
avoid formation of a brown, tar-like byproduct.  By addition of the first 
3.5 mL over 30 min and the remaining solution (~ 23 mL) over 40 min 
by syringe pump, no byproduct was seen.  
10. (S)-N-(1-Chloro-3,3-dimethylbutan-2-yl)picolinamide hydrochloride salt 
exhibited the following characterization data: 1H NMR (400 MHz, 
DMSO-d6) δ:   0.93   (s,   9  H),   3.88–3.97   (m,   2  H),   4.08   (dt,   J   =   3.6,   9.6  Hz,  
1  H),  7.68   (ddd,   J  =  1.2,  4.8,  7.2  Hz,  1  H),  8.09   (dt,   J  =  1.2,  7.6  Hz,  1  H),  
8.15  (d,   J  =  7.6  Hz,  1  H),  8.68–8.71  (m,  2  H),  13.24  (br  s,  1  H);   13C  NMR  
(100  MHz,  DMSO-­‐‑d6)   δ: 26.6,   35.3,   45.1,   59.4,   122.5,   126.9,   138.8,   147.9,  
149.0,   163.7;   IR (Neat): 3192, 3023, 2953, 2922, 1680, 1601, 1561, 1518, 
1472, 1345, 1291, 1211, 1181, 1036, 1002, 971 cm-1; HRMS (MultiMode 
ESI/FTMS) m/z calcd for C12H18ClN2O [M+H]+: 241.1102, found 
241.1103; [α]22D = +25.09 (c 1.132, MeOH). Anal calcd for C12H18Cl2N2O:  
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C, 52.00; H, 6.55; N, 10.11; Cl 25.58. Found: C, 52.29; H, 6.59; N, 10.10; Cl, 
25.57.  A broad resonance at ~ 5 ppm in the 1H NMR spectrum is found 
with incomplete drying of the product; by D2O quenching we 
determined this resonance to be the hydrate. 
11. Sodium methoxide is used from a freshly opened bottle or retrieved 
from storage in a nitrogen-atmosphere glovebox, free of adventitious 
moisture.  The addition to the reaction mixture is exothermic. 
12. The reaction can be monitored by TLC analysis using 
3:2/hexanes:acetone as the eluent, visualizing with UV fluorescence 
quenching and p-anisaldehyde staining.  Product Rf = 0.44, starting 
material Rf = 0.32. 
13. Toluene is added to prevent the crude ligand from exposure to 
concentrated sodium methoxide.  The ligand is unstable to concentrated 
acids or bases. 
14. After toluene was added, approx 140–160 mL of solvent were removed 
on the rotovap.  During the work-up and phase separation, a persistent 
rag and emulsions formed.  The rag is to be kept with the top organic 
layer.  
15. Silica gel column dimensions: 5 cm diameter x 20 cm height, ca. 200 g 
silica gel (Silica Gel ZEOprep® 60 ECO 40-63 Micron from American 
International Chemical, Inc. It is necessary to use this specific silica gel 
to suppress reversion to (S)-N-(1-hydroxy-3,3-dimethylbutan-2-
yl)picolinamide during chromatography, which was observed when 
employing silica gel from other commercial sources.  The submitters 
report the reaction’s yield is decreased by 5–10% when another silica gel 
is used.) (Note: The checker used this brand of Silica Gel as received 
from Prof. Stoltz’s lab. No other silica brands were examined) eluting 
with 4:1 hexanes/acetone.  Fractions are collected in 18 mm x 150 mm 
test tubes.  Fraction purity can be assayed by TLC analysis using 3:2 
hexanes/acetone with UV visualization. Product (3) Rf = 0.44. This slow 
eluent is used for chromatography to remove a yellow impurity of 
similar polarity that contaminates the white solid product if the column 
is eluted with higher polarity eluent.  This impurity appears to be an 
indiscrete decomposition product not readily identified.  This impurity 
is not easily removed by recrystallization, and contaminated material 
should be resubmitted to flash chromatography. 
16. (S)-tert-ButylPyOx (3) exhibited the following characterization data Rf = 
0.44 with 3:2 hexanes/acetone; mp 70.4–71.0 ºC; 1H NMR (400 MHz, 
CDCl3) δ: 0.99 (s, 9 H), 4.13 (dd, J = 8.8, 10.4 Hz, 1 H), 4.32 (t, J = 8.4 Hz, 
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1 H), 4.46 (t, J = 8.8 Hz, 1 H), 7.39 (ddd, J = 1.2, 4.4, 7.2 Hz, 1 H), 7.77 (dt, 
J = 1.2, 8.0 Hz, 1 H), 8.10 (d, J = 8.0 Hz, 1 H), 8.72 (d, J = 4.0 Hz, 1 H); 
13C NMR (100 MHz, CDCl3) δ: 26.0, 34.0, 69.3, 76.5, 124.0, 125.4, 136.5, 
147.0, 149.7, 162.5; IR (film): 2954, 2903, 2867, 1640, 1565, 1466, 1358, 
1345, 1272, 1244, 1211, 1095, 1037, 967  cm-1; HRMS (MultiMode 
ESI/APCI) m/z calcd for C12H17N2O [M+H]+: 205.1335, found 205.1336; 
[α]22D = -91.85 (c 5.09, CHCl3); Anal calcd for C12H16N2O, C 70.56, H 7.90, 
N 13.71, found C 71.09, H 8.12, N 13.29. Purity of 3 was assessed at 99.3 
wt% by quantitative 1H NMR in CDCl3 using methyl phenyl sulfone as 
a standard.  If desired, the white solid can be recrystallized from 
minimal hot n-heptane, with crystals collected at –20 °C (after cooling to 
room temperature) as white needles.  However, the ligand is more 
difficult to weigh in this state due to its tendency to cling with static 
electricity.  Enantiomeric excess can be determined via analytical chiral 
SFC (Jasco SFC utilizing a Chiralcel OB-H column (4.6 mm x 25 cm) 
obtained from Daicel Chemical Industries, Ltd) with visualization at 210 
nm and flow rate of 5 mL/min eluting with 10% MeOH/CO2. Major 
enantiomer retention time: 2.51 min, minor enantiomer retention time: 
2.20 min. (In addition to the high optical purity as seen by polarimetry, 
the material was analysed by SFC using the method above and the 
ligand was determined to be 99.7% ee.)  Attempts were made to 
separate enantiomers via analytical chiral HPLC using various columns 
(Chiralcel OD-H, Chiralcel OJ-H, Chiralpak AD, Chiralpak AS, 
Chiralcel OB-H) and solvent systems, however adequate separation of 
peaks was not achieved. In the absence of an analytical chiral SFC, 
optical rotation measurements can be utilized to give the enantiomeric 
excess by way of optical purity calculations 
(optical purity %   =   [∝]!"#$%&$'[∝]!"#$!"% × 100).  The optical rotation listed above 
may be used as αmaximal and a sufficiently large concentration (e.g. c 
5.00) as well as multiple trials should be used in order to minimize 
error.  It is imperative to store the ligand in a desiccator to minimize 
hydrolysis, which results in diminished enantiocontrol in the conjugate 
addition reaction. For long-term storage, the ligand should be stored 
frozen under an inert atmosphere; we recommend a nitrogen 
atmosphere glovebox freezer.  
17. Vigorous stirring that results in a visible vortex is essential for reaction 
conversion, as dispersion of water throughout the 1,2-dichloroethane is 
necessary. After water is added to the reaction, a viscous gel is formed 
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which prevented the magnetic stir bar from spinning. The reaction was 
manually agitated until the stir bar became free. 
18. The reaction progress can be monitored by TLC analysis with 4:1 
hexanes/ethyl acetate, using a p-anisaldehyde stain; product (6) Rf = 
0.38 (stains yellow/orange with fresh p-anisaldehyde stain), 3-methyl-2-
cyclohexenone (4) Rf = 0.19 (stains tan/brown), 4,4’-dichloro-1,1’-
biphenyl Rf = 0.65 (does not stain).  Reaction times typically are 12–24 h, 
with conversion slowing considerably after the first several hours.   
19. Silica gel plug dimensions: 3 cm diameter x 4 cm height, ca. 12 g silica 
gel. 
20. The product is very crystalline. When loading onto the column, the 
product may crystallize.  Silica gel column dimensions: 5 cm diameter x 
20 cm height, ca. 220 g silica gel (RediSep RF column from Teledyne 
Isco, catalog 69-2203-422). The column is eluted with 92:8 hexanes/ethyl 
acetate until the product is collected. Fractions are collected in 18 mm x 
150 mm test tubes.  Fraction purity can be assayed by TLC analysis 
using 4:1 hexanes/ethyl acetate with UV fluorescence quenching 
visualization and heating with p-anisaldehyde;  product (6) Rf = 0.38, 
(stains yellow/orange with fresh p-anisaldehyde stain), 3-methyl-2-
cyclohexenone (4) Rf = 0.19 (stains tan/brown),  4,4’-dichloro-1,1’-
biphenyl Rf = 0.65 (does not stain).   
21. (R)-3-(4-Chlorophenyl)-3-methylcyclohexanone (6) exhibited the 
following characterization data Rf = 0.38 (hexanes/ethyl acetate 4:1),  
1H  NMR  (400  MHz,  CDCl3)  δ:  1.30  (s,  3  H),  1.60-­‐‑1.69  (m,  1  H),  1.85-­‐‑1.94  
(m,  2  H),  2.12-­‐‑2.19  (m,  1  H),  2.31  (t,  J  =  6.8  Hz,  2  H),  2.42  (d,  J  =  14.4  Hz,  
1  H),   2.83   (d,   J   =   14.4  Hz,   1  H),   7.23-­‐‑7.25   (m,   2  H),   7.27-­‐‑7.30   (m,   2  H);  
13C  NMR   (100   MHz,   CDCl3)   δ:   21.9,   29.9,   37.9,   40.7,   42.6,   52.9,   127.1,  
128.6,   132.0,   145.8,   210.9;   IR   (thin   film):   2944,   2865,   1693,   1589,   1492,  
1450,   1432,   1352,   1265,   1229,   1092,   1010,   952,   824   759,   737,   721   cm-­‐‑1;  
HRMS (MultiMode ESI/APCI) m/z calcd for C13H14ClO [M+H]+: 
223.0884, found 223.0885;   [α]D22   =   -­‐‑65.8   (c   1.912,   CDCl3);   Anal calcd 
C13H15ClO: C 70.11, H 6.79, O 7.18, Cl 15.92 found C 69.73, H 7.02, 
O 7.49, Cl 15.88.  Enantiomeric excess of 93% is determined via 
analytical chiral HPLC (Agilent 1100 Series HPLC utilizing a Chiralcel 
OB-H column (4.6 mm x 25 cm) obtained from Daicel Chemical 
Industries, Ltd) with visualization at 254 nm and flow rate of 1 mL/min 
eluting with 1% iso-propanol/hexanes.  The sample was prepared in a 
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1:1 v/v solution of iso-propanol/hexanes.  Major enantiomer retention 
time 16.47 min, minor enantiomer retention time 14.55 min.     
 
 
Working	  with	  Hazardous	  Chemicals	  
 
The procedures in Organic Syntheses are intended for use only by 
persons with proper training in experimental organic chemistry.  All 
hazardous materials should be handled using the standard procedures for 
work with chemicals described in references such as "Prudent Practices in 
the Laboratory" (The National Academies Press, Washington, D.C., 2011; 
the full text can be accessed free of charge at 
http://www.nap.edu/catalog.php?record_id=12654).  All chemical waste 
should be disposed of in accordance with local regulations.  For general 
guidelines for the management of chemical waste, see Chapter 8 of Prudent 
Practices.  
In some articles in Organic Syntheses, chemical-specific hazards are 
highlighted in red “Caution Notes” within a procedure.  It is important to 
recognize that the absence of a caution note does not imply that no 
significant hazards are associated with the chemicals involved in that 
procedure.  Prior to performing a reaction, a thorough risk assessment 
should be carried out that includes a review of the potential hazards 
associated with each chemical and experimental operation on the scale that 
is planned for the procedure.  Guidelines for carrying out a risk assessment 
and for analyzing the hazards associated with chemicals can be found in 
Chapter 4 of Prudent Practices. 
The procedures described in Organic Syntheses are provided as 
published and are conducted at one's own risk.  Organic Syntheses, Inc., its 
Editors, and its Board of Directors do not warrant or guarantee the safety of 
individuals using these procedures and hereby disclaim any liability for any 
injuries or damages claimed to have resulted from or related in any way to 
the procedures herein. 
 
 
Discussion	  
 
Pyridinooxazoline (PyOx) ligands represent a growing class of 
bidentate, dinitrogen ligands used in asymmetric catalysis.2  Our laboratory 
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has reported the palladium-catalyzed asymmetric conjugate addition of 
arylboronic acids to cyclic, β,β-disubstituted enones utilizing (S)-tert-
ButylPyOx as the chiral ligand.3  This robust reaction does not require an 
inert atmosphere, is highly tolerant of water,4 and provides cyclic ketones 
bearing β-benzylic quaternary stereocenters in high yields and 
enantioselectivities.  While the reaction itself proved to be amenable to 
multi-gram scale, no reliable method for the large-scale synthesis of (S)-tert-
ButylPyOx was known.5 We sought to address this shortcoming by 
developing an efficient route starting from a cheap, commercially available 
precursor to pyridinooxazoline ligands.  In our initial experiments, (S)-tert-
ButylPyOx was synthesized by methanolysis of 2-cyanopyridine, and 
subsequent acid-catalyzed cyclization with (S)-tert-leucinol to afford the (S)-
tert-ButylPyOx ligand.6  We found the yields of this reaction sequence to be 
highly variable, and the purification by silica gel chromatography to be 
tedious due to the presence of numerous impurities.   
The above reported procedure begins with activation of 2-picolinic acid 
by treatment with iso-butylchloroformate and N-methylmorpholine, 
facilitating the desired amidation with (S)-tert-leucinol in high isolated 
yield, albeit requiring column chromatography.7 Many alternative coupling 
methods were screened, but mixed anhydride activation gave the highest 
yield, and the chromatographic purification proved simple even on multi-
gram scale.  Furthermore, unlike the methoxyimidate intermediate from the 
initial synthesis, (S)-N-(1-hydroxy-3,3-dimethylbutan-2-yl)picolinamide is 
bench stable at room temperature, allowing long-term storage of material.  
The cyclization of the amide alcohol to (S)–tert-ButylPyOx proved more 
challenging than anticipated.  Activation as mesylate and tosylate followed 
by in situ cyclization gave the desired product in low yield and incomplete 
conversion.  This could be a result of ligand hydrolysis under the reaction 
conditions.8  As an alternative to in situ cyclization of an activated 
intermediate, the amide alcohol was treated with thionyl chloride to yield 
the hydrochloride salt of (S)-N-(1-chloro-3,3-dimethylbutan-2-
yl)picolinamide.  After drying under vacuum, this compound proved to be 
bench stable and was spectroscopically unchanged after exposure to 
ambient atmosphere and adventitious moisture for more than one week.  
Furthermore, this chloride salt proved to be a competent cyclization 
substrate.  A series of bases were screened, and sodium methoxide was 
found to be optimal, as slower rates of hydrolysis to (S)-N-(1-hydroxy-3,3-
dimethylbutan-2-yl)picolinamide were observed when compared to the use 
of other bases.  
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Our asymmetric conjugate addition method is noteworthy for its simple 
procedure, owing to its tolerance of both water and atmospheric oxygen.  
As the catalytic, enantioselective construction of all-carbon quaternary 
stereocenters remains a challenging problem in synthetic chemistry,9 
asymmetric conjugate addition of carbon-based nucleophiles to suitable α,β-
unsaturated carbonyl acceptors has garnered much attention as a reliable 
method for the formation of quaternary stereocenters.10 However, the 
majority of well-established asymmetric conjugate additions involve the use 
of highly reactive and water-sensitive organometallic reagents (e.g., 
diorganozinc,11 triorganoaluminum,12 and organomagnesium reagents13) 
and, therefore, require rigorously anhydrous reaction conditions.  The 
notable exception is the Hayashi and Shintani rhodium/diene system,14 one 
of few quaternary-center forging reactions that avoid use of organozinc or 
organoaluminum reagents.15  Furthermore, our system advantageously uses 
commercially available arylboronic acids, as opposed to sodium 
tetraarylborates or boroxins, and palladium as the transition metal catalyst, 
as opposed to relatively rare and expensive rhodium.16  We believe these 
advantages uniquely dispose our system toward use in large-scale 
asymmetric conjugate addition reactions.  Furthermore, a large number of 
1,4-addition products have been prepared utilizing this methodology 
featuring a wide array of functional groups (Table 1). 
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Appendix	  
Chemical	  Abstracts	  Nomenclature	  (Registry	  Number)	  
	  
2-Picolinic Acid: Pyridine-2-carboxylic acid; (98-98-6) 
iso-Butylchloroformate; (543-27-1) 
N-Methylmorpholine: NMM; (109-02-4) 
(S)-tert-Leucinol: (S)-2-Amino-3,3-dimethyl-1-butanol; (112245-13-3) 
(S)-N-(1-Hydroxy-3,3-dimethylbutan-2-yl)picolinamide;  (1476785-62-2) 
thionyl chloride; (7719-09-7) 
Sodium methoxide: sodium methylate; (124-41-4) 
(S)-tert-ButylPyOx: (S)-4-(tert-Butyl)-2-(pyridin-2-yl)-4,5-dihydrooxazole 
(117408-98-7) 
Palladium(II) trifluoroacetate (42196-31-6) 
Ammonium hexafluorophosphate (16941-11-0) 
3-Methyl-2-cyclohexenone (1193-18-6) 
4-Chlorophenylboronic acid (1679-18-1) 
(R)-3-(4-Chlorophenyl)-3-methylcyclohexanone (1235989-03-3) 
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Frequency (MHz) 400.23 Nucleus 1H Number of Transients 16 Origin Bruker BioSpin GmbH
Original Points Count 32768 Owner shr-ato-nmr1 Points Count 32768 SW(cyclical) (Hz) 6410.06
Solvent DMSO-d6 Spectrum Offset (Hz) 2401.5132 Sweep Width (Hz) 6409.86 Temperature (degree C) 27.000
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Frequency (MHz) 100.65 Nucleus 13C Number of Transients 512 Origin Bruker BioSpin GmbH
Original Points Count 32768 Owner shr-ato-nmr1 Points Count 32768 SW(cyclical) (Hz) 28408.22
Solvent DMSO-d6 Spectrum Offset (Hz) 12031.0820 Sweep Width (Hz) 28407.36 Temperature (degree C) 27.000
VerticalScaleFactor = 1122106-20-1_11.dx
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Frequency (MHz) 400.23 Nucleus 1H Number of Transients 16 Origin Bruker BioSpin GmbH
Original Points Count 32768 Owner shr-ato-nmr1 Points Count 32768 SW(cyclical) (Hz) 6410.06
Solvent CHLOROFORM-d Spectrum Offset (Hz) 2397.5229 Sweep Width (Hz) 6409.86
Temperature (degree C) 27.000
VerticalScaleFactor = 1122106-21-1_10.dx
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Frequency (MHz) 100.65 Nucleus 13C Number of Transients 512 Origin Bruker BioSpin GmbH
Original Points Count 32768 Owner shr-ato-nmr1 Points Count 32768 SW(cyclical) (Hz) 28408.22
Solvent CHLOROFORM-d Spectrum Offset (Hz) 12080.1416 Sweep Width (Hz) 28407.36
Temperature (degree C) 27.000
VerticalScaleFactor = 1122106-21-1_11.dx
Chemical Shift (ppm)184 176 168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40
N
or
m
al
iz
ed
 In
te
ns
ity
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
26
.0
34
.0
69
.3
76
.5
12
4.
0
12
5.
4
13
6.
5
14
7.
0
14
9.
7
16
2.
5
4/13/2015 6:55:32 AM
Acquisition Time (sec) 5.1120 Comment cochranb Date 13 Apr 2015 06:44:44
Date Stamp 13 Apr 2015 06:44:44 File Name \\scone\nmr-archive\jcamp\cochranb\2015\122106-26-1_10.dx
Frequency (MHz) 400.13 Nucleus 1H Number of Transients 16 Origin Bruker BioSpin GmbH
Original Points Count 32768 Owner shr-ato-nmr1 Points Count 32768 SW(cyclical) (Hz) 6410.06
Solvent CHLOROFORM-d Spectrum Offset (Hz) 2393.0381 Sweep Width (Hz) 6409.86
Temperature (degree C) 27.000
VerticalScaleFactor = 1122106-26-1_10.dx
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Frequency (MHz) 100.62 Nucleus 13C Number of Transients 512 Origin Bruker BioSpin GmbH
Original Points Count 32768 Owner shr-ato-nmr1 Points Count 32768 SW(cyclical) (Hz) 28408.22
Solvent CHLOROFORM-d Spectrum Offset (Hz) 12069.4268 Sweep Width (Hz) 28407.36
Temperature (degree C) 27.000
VerticalScaleFactor = 1122106-26-1_11.dx
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